Th e clinical-economic analysis of Dupilumab in severe asthma
Background. Severe Asthma is a most social important chronic illness due to highest expenditures of Health Care System for control and treatment of exacerbations and decreasing of GDP. Situation with modern treatment is better now because biologic drugs have introduced into real practice. Biologic d...
Saved in:
Main Authors: | I. S. Krysanov (Author), V. S. Krysanova (Author), V. Yu. Ermakova (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of dupilumab on the economic burden of severe asthma and atopic dermatitis
by: I. S. Krysanov, et al.
Published: (2020) -
A social-economic burden of rhinosinusitis with nasal polyps with comorbid asthma and influence of dupilumab
by: I. S. Krysanov, et al.
Published: (2021) -
Clinical and economic justification of screening for mucopolysaccharidosis type I in children at groups of risks
by: I. S. Krysanov, et al.
Published: (2021) -
Social-economic burden of severe atopic dermatitis in the Russian Federation
by: I. S. Krysanov, et al.
Published: (2020) -
Pharmacoeconomic analysis of anemia therapy in cancer patients in real clinical practice of the Russian Federation
by: I. S. Krysanov, et al.
Published: (2019)